Lupus Trials News

The best and brightest are working toward finding better treatments and ultimately a cure for lupus. Read about how the most important influencers in the lupus community are effecting lupus research, along with other issues that matter most to you.

LRA Writes President Supporting Dr. Janet Woodcock for FDA Commissioner

March 31, 2021 As part of the LRA’s mission to accelerate development and availability of much-needed new diagnostics and treatments...

Read More

LRA Congratulates Equillium on Positive Results of Study of Potential New Lupus Treatment

March 30, 2021 Equillium, Inc. announced positive topline data from the phase 1b EQUALISE study in patients with systemic lupus...

Read More

Join LRA’s Interactive, Virtual Lupus Clinical Trials Fair on April 8th!

Join LRA’s Interactive, Virtual Lupus Clinical Trials Fair on April 8th! ·    Learn more about an upcoming study LRA is doing...

Read More

Lupus Research Alliance Hails Approval of Aurinia’s Lupkynis(TM) (voclosoporin)

First Oral Treatment for Lupus Nephritis; Second Lupus Treatment to Receive FDA Approval in Past Month NEW YORK, NY. January...

Read More

LuCIN Investigators Show that Stimulating the Vagus Nerve in Lupus Patients Decreases Pain and Fatigue

November 23, 2020 Up to 95% of lupus patients report pain and fatigue caused by the disease. To explore ways...

Read More

Promising New Lupus Treatments Highlighted ACR Annual Meeting

Results of clinical trials testing potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence...

Read More

LRA Highlights Full Continuum of Lupus Research at ACR Convergence 2020

30+ presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways Results from three clinical...

Read More

Results of Two Voclosporin Trials Presented at Key Medical Meeting

October 22, 2020 Aurinia Pharmaceuticals announced that data taken from a combined analysis of two trials, AURA-LV and AURORA underscored...

Read More

LRA-Supported Researcher Finds Similarity between COVID-19 and Lupus Flares

October 21, 2020 In a recent study published in Nature Immunology, LRA Lupus Insight Prize recipient Dr. Ignacio Sanz and colleagues found that the immune response in patients hospitalized...

Read More

Lupus Clinical Trials Redefined: You Make the Difference

Lupus Clinical Trials Redefined: You Make the Difference Lupus Clinical Trials Virtual Fair October 17, 2020 10:00 am to 1:00...

Read More

LRA Applauds GSK on Positive Phase 3 Study of Benlysta® in Lupus Nephritis

September 16, 2020 NEW YORK, NY. The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week’s...

Read More

Lupus Therapeutics Collaborating with PPD to Accelerate Lupus Clinical Research

September 3, 2020 PPD, Inc. issued a press release  today announcing its collaboration with the Lupus Research Alliance affiliate Lupus...

Read More

23andMe Study Confirms Lupus Can Run in Families and Other New Insights

August 25, 2020 A study started four years ago and conducted by 23andMe provided many insights about lupus as a...

Read More

Study Suggests Older Lupus Patients May Stop Hydroxychloroquine Without Raising Risk for Flares

August 18, 2020 A newly published study conducted by many of the research investigators who receive grant support from the...

Read More

2018 LRA Lupus Insight Prize Recipient Receives $15 M Grant from NIH to Study Lupus Effects on the Brain

July 27, 2020 The Lupus Research Alliance congratulates 2018 Lupus Insight Prize recipient Betty Diamond, MD and the Feinstein Institutes...

Read More

New Data Showed Safety and Effectiveness of Benlysta for Kids

July 27, 2020 A new international study published in Annals of the Rheumatic Diseases showed that belimumab (Benlysta) was safe...

Read More

LRA Statement: Potential Lupus Nephritis Drug Voclosporin Granted Priority Review by the U.S. FDA

NEW YORK, NY. July 22. The Lupus Research Alliance congratulates Aurinia Pharmaceuticals Inc. on acceptance of its NDA filing and...

Read More

Lupus Research Alliance Response to Janssen’s Ustekinumab Lupus Trial Discontinuation

June 26, 2020 The Lupus Research Alliance is disappointed at news from Janssen Pharmaceutical Companies of Johnson & Johnson that...

Read More

New Study Presents Strategies That Helped African-Americans Take Part In Lupus Trials

June 22, 2020 African-Americans are more likely to develop lupus than Caucasians, but less likely to take part in clinical...

Read More

Promising News from Major Medical Meeting, EULAR

Updated June 5, 2020 One of the largest meetings for rheumatologists went virtual this year to enable scientists from around...

Read More

Lupus Expert Dr. Richard Furie Addresses Clinical Trials

June 12, 2019 As reported by The Rheumatologist, Dr. Richard Furie provided his perspective on clinical trials in lupus in...

Positive Early Results for BIIB059 as New Treatment Strategy

March 1, 2019 Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...

People with Lupus at Higher Risk for Bone Fractures, Study Shows

February 22, 2019 A study published in the peer-reviewed journal Arthritis & Rheumatology found that people with SLE and particularly...

Physical Fitness Associated with Health-related Quality of Life, Study Shows

February 22, 2019 Study results published in the peer-reviewed journal PLOS One showed that elements of physical fitness — muscle...

Study Shows Kidney Transplant Improves Lupus Nephritis Survival

A study just published in Annals of Internal Medicine showed that kidney transplantation reduced deaths due to lupus nephritis— kidney inflammation caused by lupus....

Study shows: Stress, Depression and Pain are Major Contributors to Lupus Fatigue

An observational study published in Lupus of people with lupus found that of six factors,  stress, depression and pain contributed most to...

Existing Asthma Medication Shows Effectiveness for Lupus

A small randomized Phase 1 study published in Arthritis & Rheumatology found that the existing asthma treatment omalizumab (Xolair) may improve lupus...

New Trial Begins to Test Investigational Cenerimod to Treat Lupus

Source: Idorsia LTD Press Release Idorsia Ltd (SIX: IDIA)  announced that the first patient has been enrolled into a multiple-dose study...

Poor Dental Care Associated with Lupus

A study just published in Clinical and Experimental Rheumatologyfound that exposure to periodontal bacteria on the gums around the teeth can...

Association Between Lupus and Cancer

A new analysis published in Arthritis Research & Therapy found that SLE is associated with increased risk of 16 cancers and decreased...